Athene Holding’s latest portfolio disclosure offers asset managers a practical reference point for a long-running change in insurance investing: a move towards structured products and other alternatives, with less reliance on traditional bonds. Athene is among the firms at the forefront of that transition. Its investments therefore provide a case study for managers considering how to develop products for insurers, although the available material does not establish how closely other insurance companies’ portfolios resemble its own.

The broader commercial backdrop includes considerable scale.5 trillion in assets under management at the end of the third quarter, with executives identifying private markets and changes in pension funds as areas of opportunity. That figure measures BlackRock’s overall business, not insurance assets or Athene’s investments. The supplied material contains no allocation amounts, portfolio weights or performance figures for Athene, so it supports an assessment of the direction of insurance investing rather than a numerical comparison of portfolios.

The distinction matters because the insurance shift is not presented as a sudden response to a single event. Insurers have been increasing their use of structured products and other alternatives while reducing their dependence on more conventional bonds over time. Athene’s latest disclosure sits within that established trend. For an asset manager, its value is consequently less as evidence of a new market opening than as an example of how an insurer already participating in the transition is investing.

Read more: Analysts warn widening French riots could trigger bank deposit flight

That makes product development a relevant question for managers. If insurers are looking beyond traditional bond portfolios, managers have reason to examine whether their offerings address that broader investment interest. But the case for developing a product is different from the case for assuming widespread demand for it. Athene’s position at the forefront of the shift makes its portfolio informative; it does not, by itself, show that the same investments would suit insurers with different capabilities or establish the size of the potential market.

The categories also need to remain distinct. Structured products and alternatives feature in the description of the insurance investment shift, while accompanying sector headlines address private credit; the available material does not provide a breakdown showing their respective roles at Athene. Treating those labels as a single allocation would obscure rather than clarify the investment picture. A manager assessing the disclosure would need to distinguish the specific investment opportunities it illustrates from the broader proposition that insurers are becoming less dependent on traditional bonds.

A potential counterweight to the growth opportunity is expertise. An accompanying insurance-sector headline identifies rising enthusiasm for private credit while warning that many insurers lack the expertise to pursue it well. That suggests a different product-development challenge from simply expanding the range of investments on offer. For managers, a relevant question is whether an offering would match an insurer’s ability to assess it. Greater interest in an asset class should not be taken as evidence that every prospective investor is equally prepared to use it.

Read more: S&P 500 finishes little changed as banks report and memory-chip shares fall

Credit quality supplies another caution. Another sector headline highlights widening credit-quality gaps as insurance allocations to private credit rise. That cautions against a straightforward reading of growing allocations as an unqualified positive. The direction of investment demand and the quality of the resulting portfolios are separate questions. Without Athene-specific allocation and performance figures in the supplied material, there is no basis for concluding that its approach has produced either superior outcomes or greater credit problems than those of other insurers.

Concentration adds a further dimension to the assessment. An accompanying insurance-sector headline flags the artificial-intelligence boom as a source of hidden portfolio risk, with insurers facing concentration across sectors. A question for managers considering new insurance products is whether moving beyond traditional bonds also reduces concentration. This is a question for portfolio scrutiny, not a finding about Athene: the available material does not identify its artificial-intelligence exposure or demonstrate that its investments carry the concentration concerns described in the broader sector context.

BlackRock’s results place these questions within a wider asset-management opportunity, but also underline the importance of keeping the evidence separate. Its executives pointed to both private markets and structural changes in pension funds, rather than attributing the firm’s record assets solely to insurers.5 trillion total therefore cannot measure the insurance opportunity suggested by Athene’s disclosure. It offers context for managers’ interest in developing institutional businesses, while Athene provides the more directly relevant example of changing insurance investment choices.

For asset managers, one approach is to test product ideas against questions suggested by the disclosure and the broader sector context: investment type, insurer expertise, credit quality and potential concentration. More detailed allocation evidence would be needed to quantify the opportunity or compare Athene with peers. The supported conclusion is narrower but still commercially relevant. Insurers’ movement beyond traditional bonds gives managers reason to reconsider their offerings, while the accompanying cautions argue against treating a leading firm’s portfolio as a template for the entire sector.